Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Wellcome/MRC Cambridge Stem Cell Institute · Cancer Research Institute · +3 more institutions
Abstract
The stromal microenvironment of tumors, which is a mixture of hematopoietic and mesenchymal cells, suppresses immune control of tumor growth. A stromal cell type that was first identified in human cancers expresses fibroblast activation protein-α (FAP). We created a transgenic mouse in which FAP-expressing cells can be ablated. Depletion of FAP-expressing cells, which made up only 2% of all tumor cells in established Lewis lung carcinomas, caused rapid hypoxic necrosis of both cancer and stromal cells in immunogenic tumors by a process involving interferon-γ and tumor necrosis factor-α. Depleting FAP-expressing cells in a subcutaneous model of pancreatic ductal adenocarcinoma also permitted immunological…
Citation impact
- FWCI
- 23.95
- Percentile
- 100%
- References
- 30
Authors
9- MKMatthew KramanCorresponding
Wellcome/MRC Cambridge Stem Cell Institute
- PBPaul BambroughCorresponding
Wellcome/MRC Cambridge Stem Cell Institute
- JNJames N. ArnoldCorresponding
Wellcome/MRC Cambridge Stem Cell Institute
- EWEdward W. Roberts
Wellcome/MRC Cambridge Stem Cell Institute
- ŁMŁukasz Magiera
Wellcome/MRC Cambridge Stem Cell Institute
Topics & keywords
- Stromal cell
- Cancer research
- Fibroblast activation protein, alpha
- Immune system
- Tumor microenvironment
- Tumor necrosis factor alpha
- Biology
- Lymph node stromal cell
- Good health and well-being